Loved loved the discussion with Samy and RadAI founders!

The sphere in Vegas is cool. Would love to see more structures like this in general! ⁦⁦Google Cloud⁩ Next

Excited to rep Cellino and techbio founders at Google Cloud Next in Las Vegas!! Let the biotech invasion begin 🚀🚀🚀🚀🚀🔥🔥🔥🔥

See you in Vegas!!!

had a heart- and soul warming time in Aruba with hubby and baby! 🌴🌴🌴🌴🏖️🏖️🏖️🏖️ now back to some exciting work. 😍 important for me to get my sunshine fix in the last stages of winter in Boston! 🙌🏼

.Tobi Coker will be onstage with Nabiha Saklayen and @juliaaneagu at TechCrunch Early Stage in Boston on April 25th.

Don't miss their session all about TAM:

techcrunch.com/2024/03/12/fel…

🚀 We're excited for #GoogleCloudNext in #Vegas ! Join our CEO Nabiha Saklayen in a panel discussion w/other #technology experts & #innovators on 'Transforming Healthcare with Google Cloud AI' on 4/9 at 2:15 PM PDT. We hope to see you all there! Google Cloud

🗓️ bit.ly/3Ps5Zx4

Come hang out with me next week!!

Purple!!! ⁦Cellino⁩ 💜💜💜💜💜

We've been selected as a spoke in the Investor Catalyst Hub network, which is focused on accelerating #patient -centric #healthcare innovations & delivering improved outcomes for all. #ARPANETH 🚀

Learn more about the ARPA-H nationwide #healthinnovation network: bit.ly/4bXjlLx

🚀 TechCrunch Early Stage 2024 is returning to #Boston ! Excited for our CEO Nabiha Saklayen to join Tobi Coker of Felicis & @juliaaneagu of Quotient AI. They'll discuss 'How to Intelligently Calculate Your TAM and Wow Investors.' 🌟 Register and join us!

tcrn.ch/3TezDYW

Excited to share the stage at TechCrunch Early Stage this year with Nabiha Saklayen Julia Neagu! Please come say hi if you will be in attendance.

techcrunch.com/2024/02/13/tec…

Your chance to work with a star!!

Just got an update email from a rising superstar founder. And her email was just beautiful and I took notes. The learning never stops!!! 🚀🚀🚀🚀🚀🚀

Today we should celebrate the perseverance of $VRTX in translating the incredible human genetics of Nav 1.8 for pain into a drug with Phaase 3 data ready for approval. The commercial market can debate the differentiation and merits vs existing generics, but it should be a huge…

Thank you to everyone who joined yesterday for the GEN Biotechnology panel on Automation & Manufacturing Solutions in Cell & Gene Therapy. It was a great experience discussing this topic with Lexi Rovner of 64x Bio and Fabian Gerlinghaus of @Cellares!

1. Oh. My. GREGOR!!! (and Rosalind)
investor.lilly.com/news-releases/…
2. Editing has worked in nonclinical models of hearing loss (eg David R. Liu pubmed.ncbi.nlm.nih.gov/29258297/)
3. We have to leverage advances in viral gene therapy to CRISPR cures in this space.

Huge news coming out of Eli Lilly and Company subsidiary Akouos. Hearing restoration observed within 30 days of therapy administration, a US gene therapy first. Congrats to Manny Simons and the team!

investor.lilly.com/news-releases/…

I’ve made or seen hundreds of hires, and one thing I have never seen is a B player hire an A player. Not once.

If you play that out, you realize that compromising on even a single role can destroy a team forever.

coming soon: site finder for our LOY-002 lifespan extension study

one of the top questions i get is how can you + your dog can participate in a Loyal study - soon will be much easier to get involved :)